NIASPAN

This brand name is authorized in United States. It is also authorized in Hong Kong SAR China, Singapore, South Africa.

Active ingredients

The drug NIASPAN contains one active pharmaceutical ingredient (API):

1	Nicotinic acid UNII 2679MF687A - NIACIN
	Niacin (nicotinic acid) is an essential B complex Vitamin (B3), whose deficiency results in the clinical syndrome known as pellagra. Nicotinamide (niacinamide), the active ingredient, is the physiologically active form of niacin and is the chemical form of Vitamin B3 found in virtually all multivitamin products. Though nicotinic acid and nicotinamide are so closely related chemically, they differ somewhat in pharmacological properties.
	Read more about Nicotinic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NIASPAN Film coated tablet / Extended-release tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AD02	Nicotinic acid	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AD Nicotinic acid and derivatives
Discover more medicines within C10AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	60373, 60374
SG	Health Sciences Authority	13037P, 13039P
US	FDA, National Drug Code	0074-3265, 0074-3274, 0074-3275
ZA	Health Products Regulatory Authority	A39/7.5/0245, A39/7.5/0246, A39/7.5/0247, A39/7.5/0248